Settore scientifico disciplinare: 


  • Ceppi, L., Grassi, T., Galli, F., Buda, A., Aletti, G., Lissoni, A., et al. (2021). Early-stage clear cell ovarian cancer compared to high-grade histological subtypes: An outcome exploratory analysis in two oncology centers. GYNECOLOGIC ONCOLOGY, 160(1), 64-70. Dettaglio
  • Conconi, D., Redaelli, S., Lissoni, A., Cilibrasi, C., Perego, P., Gautiero, E., et al. (2021). Genomic and epigenomic profile of uterine smooth muscle tumors of uncertain malignant potential (Stumps) revealed similarities and differences with leiomyomas and leiomyosarcomas. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 22(4), 1-16. Dettaglio
  • Di Martino, G., Lissoni, A., Ferrari, D., Di Meo, M., Cosio, S., Gadducci, A., et al. (2021). Dose-dense neoadjuvant chemotherapy with paclitaxel and carboplatin in cervical cancer: Efficacy on pathological response. ANTICANCER RESEARCH, 41(1), 497-502 [10.21873/anticanres.14800]. Dettaglio
  • Post, C., de Boer, S., Powell, M., Mileshkin, L., Katsaros, D., Bessette, P., et al. (2021). Long-term toxicity and health-related quality of life after adjuvant chemoradiotherapy or radiotherapy alone for high-risk endometrial cancer in the randomised PORTEC-3 trial. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 109(4 (15 March 2021)), 975-986 [10.1016/j.ijrobp.2020.10.030]. Dettaglio
  • Gadducci, A., Cosio, S., Lissoni, A., Zizioli, V., Adorni, M., Ferrero, A., et al. (2020). Imact of bevacizumab-containing primary treatment on outcome of recurrent ovarian cancer: An Italian study. ANTICANCER RESEARCH, 40(3), 1543-1550 [10.21873/anticanres.14100]. Dettaglio